ARVINAS, INC. ARVN

Rank #2116 · Nasdaq · $0.5B market cap

Audited by Deloitte & Touche LLP, no going-concern flag in the latest filing.

Score

33.2

P/E

-1.4

P/B

0.90

ROE

-65.0%

Op. Margin

-511.5%

Debt Ratio

94%

Health Check — percentile rank within this universe, based on the latest annual filing

Valuation ★★☆☆☆

Average

P/E -1.4x, P/B 0.90x. Ranks in the top 54% of the universe.

Profitability ★☆☆☆☆

Poor

ROE -65.0%. Ranks in the top 92% of the universe.

Safety ★★★☆☆

Good

Debt ratio 94%. Ranks in the top 37% of the universe.

Growth ★☆☆☆☆

Poor

Revenue decline of 40.3% year over year. Ranks in the top 96% of the universe.

Safety is the relative strength · Profitability is the relative weakness (relative to this universe).

FY	Revenue	Op. Income	Net Income	Equity	Op. Margin%	Debt%
2018	$0.0B	$-0.0B	$-0.0B	$-0.0B	-326.7	-203
2019	$0.0B	$-0.0B	$-0.0B	$-0.1B	-305.8	-102
2020	$0.0B	$-0.0B	$-0.0B	$-0.1B	-305.8	-122
2021	$0.0B	$-0.1B	$-0.1B	$0.1B	-119.8	55
2022	$0.0B	$-0.1B	$-0.1B	$0.2B	-466.4	353
2023	$0.1B	$-0.2B	$-0.2B	$0.6B	-351.5	110
2024	$0.1B	$-0.3B	$-0.3B	$0.8B	-200.3	82
2025	$0.1B	$-0.4B	$-0.4B	$0.6B	-511.5	94